Related Experiment Video

Updated: Mar 24, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K

Recent Developments in Pediatric Community-Acquired Pneumonia

Russell J McCulloh1,2, Karisma Patel3

  • 1Division of Infectious Diseases, Children's Mercy Hospital, 2401 Gillham Road, Kansas City, MO, 64108, USA. rmcculloh@cmh.edu.

Current Infectious Disease Reports
|March 11, 2016
PubMed

Insights

This review covers key 2014-2015 findings in pediatric community-acquired pneumonia (CAP), focusing on epidemiology, diagnostics, and treatment. It highlights vaccination

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Community-acquired pneumonia (CAP) is a leading cause of infectious death in children globally.
  • Research in pediatric CAP encompasses epidemiology, diagnosis, treatment, and prevention.
  • Significant advancements in understanding and managing pediatric CAP have been reported.

Purpose of the Study:

  • To review key findings in pediatric CAP research from 2014-2015.
  • To focus on clinical management aspects of pediatric CAP.
  • To synthesize recent advances in epidemiology, diagnostics, and treatment.

Main Methods:

  • Literature review of pediatric CAP research published in 2014-2015.
  • Focus on significant findings relevant to clinical management.
  • Categorization of findings into epidemiology, diagnostics, treatment, and policy.

Main Results:

  • Recent advances in understanding global CAP epidemiology, including the impact of vaccination.
  • Expanding role of diagnostic technologies for CAP classification and management.
  • Progress in optimizing antimicrobial use and clinical practice guidelines.

Conclusions:

  • Vaccination plays a crucial role in preventing pediatric CAP.
  • Diagnostic technologies are improving CAP classification and management.
  • Optimized antimicrobial use and updated guidelines enhance clinical management and patient outcomes.

Keywords:
Community-acquired pneumoniaMolecular diagnosticsPediatricPneumococcusViral pneumonia

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.3K
Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

52.6K

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.9K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.0K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
17
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.0K